MORGAN STANLEY

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 895421 NEW YORK, NY

Back to VRTX Full portfolio

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,423,962,911

+$9,339,179 QoQ

Shares Held

3,188,881

+2.2% QoQ

Ownership

1.26%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 83.42261752633604.ToString("F0")% Shared 0.ToString("F0")% None 16.57738247366396.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. VRTX ranks #3 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma This page	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

All Filings in VRTX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,423,962,911	3,188,881	+2.2%	Shares	Defined	2026-05-15
2025-12-31	$1,414,623,732	3,120,310	+0.4%	Shares	Defined	2026-05-27
2025-09-30	$1,217,375,725	3,108,405	-6.7%	Shares	Defined	2026-05-27
2025-06-30	$1,483,156,634	3,331,439	-2.3%	Shares	Defined	2025-08-15
2025-03-31	$1,652,518,655	3,408,520	+7.5%	Shares	Defined	2025-05-15
2024-12-31	$1,277,117,537	3,171,387	+4.4%	Shares	Defined	2025-05-15
2024-09-30	$1,413,116,271	3,038,437	-6.8%	Shares	Defined	2025-05-14
2024-06-30	$1,527,384,104	3,258,628	+2.3%	Shares	Defined	2025-05-14
2024-03-31	$1,331,138,622	3,184,466	+6.8%	Shares	Defined	2024-10-17
2023-12-31	$1,212,717,323	2,980,455	+3.8%	Shares	Defined	2024-08-16
2023-09-30	$998,048,913	2,870,101	+3.2%	Shares	Defined	2023-11-15
2023-06-30	$978,620,878	2,780,884	+18.2%	Shares	Defined	2023-08-14
2023-03-31	$741,378,922	2,353,061	-8.7%	Shares	Defined	2023-05-15
2022-12-31	$744,603,051	2,578,444	+33.1%	Shares	Defined	2023-02-14
2022-09-30	$560,996,773	1,937,545	+6.0%	Shares	Defined	2022-11-14
2022-06-30	$514,893,727	1,827,225	+121.3%	Shares	Defined	2022-10-27
2022-03-31	$215,521,809	825,849	-14.8%	Shares	Defined	2022-10-27
2021-12-31	$212,969,613	969,807	-7.0%	Shares	Defined	2022-02-14
2021-09-30	$189,101,427	1,042,513	-14.6%	Shares	Defined	2021-11-15
2021-06-30	$246,255,953	1,221,326	+36.4%	Shares	Defined	2021-08-23
2021-03-31	$192,408,633	895,382	-2.4%	Shares	Defined	2021-05-17
2020-12-31	$216,924,192	917,848	+18.7%	Shares	Defined	2021-02-16
2020-09-30	$210,491,073	773,523	+12.3%	Shares	Defined	2020-11-13
2020-06-30	$199,999,778	688,918	+2.0%	Shares	Defined	2020-08-14
2020-03-31	$160,734,031	675,495	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.